Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure
Background; In patients with chronic heart failure (CHF) increasing levels of total serum cholesterol are associated with improved survival - while statin usage is not. The impact of statin treatment on the “reverse epidemiology” of cholesterol is unclear. Methods: 2992 consecutive patients with non...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
9 March 2017
|
| In: |
International journal of cardiology
Year: 2017, Jahrgang: 238, Pages: 97-104 |
| ISSN: | 1874-1754 |
| DOI: | 10.1016/j.ijcard.2017.03.028 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.ijcard.2017.03.028 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0167527317315231 
|
| Verfasserangaben: | Hanna Fröhlich, Nandita Raman, Tobias Täger, Dieter Schellberg, Kevin M. Goode, Syed Kazmi, Morten Grundtvig, Torstein Hole, John G. F. Cleland, Hugo A. Katus, Stefan Agewall, Andrew L. Clark, Dan Atar, Lutz Frankenstein |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1575523043 | ||
| 003 | DE-627 | ||
| 005 | 20220814145817.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180525s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijcard.2017.03.028 |2 doi | |
| 035 | |a (DE-627)1575523043 | ||
| 035 | |a (DE-576)505523043 | ||
| 035 | |a (DE-599)BSZ505523043 | ||
| 035 | |a (OCoLC)1341010098 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Fröhlich, Hanna |d 1985- |e VerfasserIn |0 (DE-588)1014274141 |0 (DE-627)705202550 |0 (DE-576)348549091 |4 aut | |
| 245 | 1 | 0 | |a Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure |c Hanna Fröhlich, Nandita Raman, Tobias Täger, Dieter Schellberg, Kevin M. Goode, Syed Kazmi, Morten Grundtvig, Torstein Hole, John G. F. Cleland, Hugo A. Katus, Stefan Agewall, Andrew L. Clark, Dan Atar, Lutz Frankenstein |
| 264 | 1 | |c 9 March 2017 | |
| 300 | |b Illustrationen | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 25.05.2018 | ||
| 520 | |a Background; In patients with chronic heart failure (CHF) increasing levels of total serum cholesterol are associated with improved survival - while statin usage is not. The impact of statin treatment on the “reverse epidemiology” of cholesterol is unclear. Methods: 2992 consecutive patients with non-ischemic CHF due to left ventricular systolic dysfunction from the Norwegian CHF Registry and the CHF Registries of the Universities of Hull, UK, and Heidelberg, Germany, were studied. 1736 patients were individually double-matched on both cholesterol levels and the individual propensity scores for statin treatment. All-cause mortality was analyzed as a function of baseline cholesterol and statin use in both the general and the matched sample. Results: 1209 patients (40.4%) received a statin. During a follow-up of 13,740 patient-years, 360 statin users (29.8%) and 573 (32.1%) statin non-users died. When grouped according to total cholesterol levels as low (≤3.6mmol/L), moderate (3.7-4.9mmol/L), high (4.8-6.2mmol/L), and very high (>6.2mmol/L), we found improved survival with very high as compared with low cholesterol levels. This association was present in statin users and non-users in both the general and matched sample (p<0.05 for each group comparison). The negative association of total cholesterol and mortality persisted when cholesterol was treated as a continuous variable (HR 0.83, 95%CI 0.77-0.90, p<0.001 for matched patients), but it was less pronounced in statin users than in non-users (F-test p<0.001). Conclusions: Statins attenuate but do not eliminate the reverse epidemiological association between increasing total serum cholesterol and improved survival in patients with non-ischemic CHF. | ||
| 650 | 4 | |a Chronic heart failure | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Reverse epidemiology | |
| 650 | 4 | |a Serum cholesterol | |
| 650 | 4 | |a Statins | |
| 700 | 1 | |a Raman, Nandita |e VerfasserIn |0 (DE-588)1160108803 |0 (DE-627)1023262630 |0 (DE-576)505523833 |4 aut | |
| 700 | 1 | |a Täger, Tobias |d 1981- |e VerfasserIn |0 (DE-588)1026375959 |0 (DE-627)726658243 |0 (DE-576)370501403 |4 aut | |
| 700 | 1 | |a Schellberg, Dieter |e VerfasserIn |0 (DE-588)1028373023 |0 (DE-627)730619974 |0 (DE-576)375906010 |4 aut | |
| 700 | 1 | |a Katus, Hugo |d 1951- |e VerfasserIn |0 (DE-588)108916618 |0 (DE-627)577155040 |0 (DE-576)289625076 |4 aut | |
| 700 | 1 | |a Frankenstein, Lutz |d 1973- |e VerfasserIn |0 (DE-588)124198937 |0 (DE-627)63440766X |0 (DE-576)328373281 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of cardiology |d Amsterdam [u.a.] : Elsevier Science, 1981 |g 238(2017), Seite 97-104 |h Online-Ressource |w (DE-627)306659581 |w (DE-600)1500478-8 |w (DE-576)081986270 |x 1874-1754 |7 nnas |a Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure |
| 773 | 1 | 8 | |g volume:238 |g year:2017 |g pages:97-104 |g extent:8 |a Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijcard.2017.03.028 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0167527317315231 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180525 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 124198937 |a Frankenstein, Lutz |m 124198937:Frankenstein, Lutz |d 910000 |d 910100 |e 910000PF124198937 |e 910100PF124198937 |k 0/910000/ |k 1/910000/910100/ |p 14 |y j | ||
| 998 | |g 108916618 |a Katus, Hugo |m 108916618:Katus, Hugo |d 910000 |d 910100 |e 910000PK108916618 |e 910100PK108916618 |k 0/910000/ |k 1/910000/910100/ |p 10 | ||
| 998 | |g 1028373023 |a Schellberg, Dieter |m 1028373023:Schellberg, Dieter |d 910000 |d 910100 |e 910000PS1028373023 |e 910100PS1028373023 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1026375959 |a Täger, Tobias |m 1026375959:Täger, Tobias |d 910000 |d 910100 |e 910000PT1026375959 |e 910100PT1026375959 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1160108803 |a Raman, Nandita |m 1160108803:Raman, Nandita |d 910000 |d 910100 |e 910000PR1160108803 |e 910100PR1160108803 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1014274141 |a Fröhlich, Hanna |m 1014274141:Fröhlich, Hanna |d 910000 |d 910100 |e 910000PF1014274141 |e 910100PF1014274141 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1575523043 |e 3010183496 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"name":{"displayForm":["Hanna Fröhlich, Nandita Raman, Tobias Täger, Dieter Schellberg, Kevin M. Goode, Syed Kazmi, Morten Grundtvig, Torstein Hole, John G. F. Cleland, Hugo A. Katus, Stefan Agewall, Andrew L. Clark, Dan Atar, Lutz Frankenstein"]},"recId":"1575523043","person":[{"given":"Hanna","display":"Fröhlich, Hanna","family":"Fröhlich","role":"aut"},{"given":"Nandita","display":"Raman, Nandita","role":"aut","family":"Raman"},{"family":"Täger","role":"aut","display":"Täger, Tobias","given":"Tobias"},{"display":"Schellberg, Dieter","given":"Dieter","family":"Schellberg","role":"aut"},{"role":"aut","family":"Katus","given":"Hugo","display":"Katus, Hugo"},{"display":"Frankenstein, Lutz","given":"Lutz","family":"Frankenstein","role":"aut"}],"note":["Gesehen am 25.05.2018"],"title":[{"title_sort":"Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure","title":"Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1575523043"],"doi":["10.1016/j.ijcard.2017.03.028"]},"physDesc":[{"extent":"8 S.","noteIll":"Illustrationen"}],"relHost":[{"recId":"306659581","id":{"eki":["306659581"],"issn":["1874-1754"],"zdb":["1500478-8"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"International journal of cardiology","title":"International journal of cardiology"}],"origin":[{"dateIssuedDisp":"1981-","publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1981"}],"part":{"extent":"8","pages":"97-104","text":"238(2017), Seite 97-104","volume":"238","year":"2017"},"language":["eng"],"pubHistory":["1.1981 -"],"note":["Gesehen am 13.02.20","Ungezählte Beil.: Supplement"],"disp":"Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failureInternational journal of cardiology","type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedDisp":"9 March 2017","dateIssuedKey":"2017"}]} | ||
| SRT | |a FROEHLICHHSTATINSATT9201 | ||